Neutralizing antibodies against GIP receptor activity were observed in only 1.9 percent of patients
[00:08:23.390] Well, David, weve had conversations at Lid with with retail, North American-based retailers, global in scale, some of them, who, when theyre thinking about their Canadian supply chain, are asking themselves, well, if Im going to renew my Canadian infrastructure and put a large facility and put a large amount of capital into the greater Toronto area, and Im going to have a Canadian e-commerce operation anyway, why not greatly expand grant that operation and run my entire North American e-commerce operation there because the de minimis loophole allows me to

UnitedHealthcare Medicare Advantage Zepbound coverage as of May 2026: Standard obesity indication: generally excluded under Medicare Part D weight-loss drug rules OSA indication (after December 2024): coverage path with sleep-medicine documentation 2025 IRA $2,000 annual out-of-pocket cap applies to covered Part D drugs Members seeking Zepbound coverage through UnitedHealthcare Medicare Advantage should pursue the OSA indication when applicable, as obesity-only requests typically face exclusion
SLE is a chronic autoimmune condition that affects around 1 in 1,000 people in the UK and is around six times more common in women than men
It hurts and swells
Goals get met